20:01 , Feb 1, 2018 |  BC Innovations  |  Translation in Brief

New Therapeutic Targets and Biomarkers: January 2018

New Therapeutic Targets and Biomarkers: January 2018...
21:13 , Jan 23, 2018 |  BC Innovations  |  Distillery Therapeutics

Endocrine / Metabolic

INDICATION: Diabetes Patient sample and mouse studies suggest inhibiting miR-181a or NFAT5 could help treat islet autoimmunity, a precursor to Type I diabetes. In blood samples from children of Type I diabetes patients, T cell...